Search for: "Noble v. Allness et al" Results 61 - 80 of 81
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Oct 2014, 5:27 am
 The compiler, as ever, is the suave and sophisticated Alberto Bellan, to whom we are all indebted. [read post]
13 Oct 2007, 7:52 am
I must, of course, leave this rather long post with a bit of Shakespeare - Henry V: O noble English! [read post]
5 Dec 2008, 3:00 pm
(The Prior Art) Ways to avoid a USPTO ethics investigation (IP Updates)   US Patents – Decisions CAFC: Qualcomm penalised for failure to disclose patents to standard setting organisation and for litigation misconduct in failing to produce evidence: Qualcomm Inc v Broadcom Corp (IP Law Observer) (Patently-O) (Promote the Progress) (Law360) (Patent Prospector) (Hal Wegner) (PLI) CAFC upholds judgment enjoining inventor from asserting patent against Unitronics or its… [read post]
30 Oct 2011, 8:59 pm by Schachtman
” Michele Carbone et al., “Modern Criteria to Establish Human Cancer Etiology,” 64 Cancer Res. 5518, 5522 (2004).) [read post]
16 Jan 2009, 7:00 am
(IP Dragon) Patent strategies for foreign R&D work in China (Philip Brooks' Patent Infringement Updates) All clichés but still true: Intellectual Property Rights enforcement in China leaves room for improvement (IP Dragon) Recognition and protection of well-known trade marks (International Law Office) Revised Chinese patent law aims at quality, compulsory licensing (Intellectual Property Watch) Zen and the art of intellectual property in China (IP Dragon)  … [read post]
21 Feb 2011, 9:25 am by Charon QC
It is fair to say that the noble Savage has become something of an Aunt Sally. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]